Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2020
Survival and prognostic factors in patients with rectal squamous cell carcinomaAnuhya Kommalapati, Sri Harsha Tella, Siddhartha Yadav, et al.
Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.
Investigational New Drugs|August 16, 2015
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignanciesAmit Mahipal, Dave Shibata, Erin Siegel, et al.
Cancers|January 8, 2023
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current GuidelinesAmr Mohamed, Sulin Wu, Mohamed Hamid, et al.
Pancreas|July 24, 2018
Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the PancreasBrandon M Huffman, Gustavo Westin, Samer Alsidawi, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2015
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancerYaman Suleiman, Amit Mahipal, David Shibata, et al.
Journal of Gastrointestinal Oncology|May 22, 2026
Multi-institutional care is associated with improved survival in biliary tract cancerTrisha Lal, Jay Han, Natalie N Chakraborty, et al.
JCO Oncology Practice|March 4, 2025
Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent TreatmentVeronica Mears, Nikolas Naleid, Omkar Pawar, et al.
Expert Opinion on Therapeutic Targets|January 17, 2022
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implicationsLionel A Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, et al.
Cancers|October 14, 2023
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence StudyMathias E Palmer, Jennifer J Gile, Michael H Storandt, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2020
Survival and prognostic factors in patients with rectal squamous cell carcinomaAnuhya Kommalapati, Sri Harsha Tella, Siddhartha Yadav, et al.
Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.
Investigational New Drugs|August 16, 2015
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignanciesAmit Mahipal, Dave Shibata, Erin Siegel, et al.
Cancers|January 8, 2023
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current GuidelinesAmr Mohamed, Sulin Wu, Mohamed Hamid, et al.
Pancreas|July 24, 2018
Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the PancreasBrandon M Huffman, Gustavo Westin, Samer Alsidawi, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2015
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancerYaman Suleiman, Amit Mahipal, David Shibata, et al.
Journal of Gastrointestinal Oncology|May 22, 2026
Multi-institutional care is associated with improved survival in biliary tract cancerTrisha Lal, Jay Han, Natalie N Chakraborty, et al.
JCO Oncology Practice|March 4, 2025
Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent TreatmentVeronica Mears, Nikolas Naleid, Omkar Pawar, et al.
Expert Opinion on Therapeutic Targets|January 17, 2022
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implicationsLionel A Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, et al.
Cancers|October 14, 2023
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence StudyMathias E Palmer, Jennifer J Gile, Michael H Storandt, et al.
Pageof 18